RelayPro Thoracic Stent-Graft System 28-N4-36-259-36URecalls & reported problems
Bolton Medical Inc. · Endovascular Stent-Graft System · Class 3 · Implant
All models of RelayPro Thoracic Stent-Graft System (127)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 1
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00843576150874), received between Sep 25, 2024 and Sep 25, 2024 — classified as 1 malfunction.
The most frequently reported specific device problem is “Activation, Positioning or Separation Problem” (1 report).
1 FDA recall record name this device's identifier, 1 still open.
1 other recall cover devices cleared under the same FDA submission (P200045); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Recalls naming this device
- Apr 22, 2026Class IOpen, Classified
Labeling update concerning proximal clasp disconnection from the outer control tube which may prevent stent graft from being released from the delivery system.
Z-2160-2026 · Root cause: Under Investigation by firm · Recall details · FDA record ↗
Most reported problems
Device problems
- Activation, Positioning or Separation Problem1
- Difficult or Delayed Separation1
- Separation Problem1
Patient problems
- No Clinical Signs, Symptoms or Conditions1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
MalfunctionSep 25, 2024Activation, Positioning or Separation Problem; Separation Problem; Difficult or Delayed Separation; Activation, Positioning or Separation Problem; Separation Problem; Difficult or Delayed Separation
"PHYSICIAN CHOSE 36-100 GRAFT TO LAND AT LSA. INTRODUCED GRAFT ONTO THE WIRE IN POSITION 1, ADVANCED PROXIMAL OUTER SHEATH/TIP TO DISTAL LANDING ZONE. THEN ADVANCED INNER SHEATH TO LSA WHICH IS THE PROX LANDING ZONE. PUT CONTROLLER KNOB IN POSITION 2. HAD RESIDENT TURN THE DEPLOYMENT GRIP COUNTERCLOCKWISE TO UNSHEATH THE FIRST COVERED STENT. THE RESIDENT CONTINUED TO TURN THE DEPLOYMENT GRIP BUT NOTHING MOVED. AT THE SAME TIME THE DEPLOYMENT GRIP BUTTON WAS DEPRESSED. WE TRIED DIFFERENT TROUBLESHOOTING TECHNIQUES AND CONTINUED TO TRY TO UNSHEATH THE INNER SHEATH BUT NOTHING MOVED. FINALLY, DR (B)(6) SCRUBBED IN, MOVED THE DISENGAGEMENT BUTTON A FEW TIMES, TRIED TO ROTATE THE DEPLOYMENT GRIP WITH NO LUCK, THEN PUSHED THE BUTTON DOWN AND PULLLED BACK WITH SOME FORCE TO DEPLOY THE GRAFT. WHEN THE RESIDENT WENT TO STEP3 TO RELEASE THE GRAFT FROM THE DEPLOYMENT SYSTEM IT WOULD LOCK IN PLACE SO WE HELD THEM TOGETHER WHILE RETRACTING THE TIP BACK INTO THE SHEATH. GRAFT IS IN BIOHAZARD BAG AT THE HOSPITAL WAITING FOR THE REP TO COME BACK FROM VACATION TO RETURN IT. REP NAME (B)(6). UPDATE OF EVENT NARRATIVE (RECEIVED ON 09/23/2024): WE ARE INITIATING AN ADDITIONAL COMPLAINT FOR THE FIRST R
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 20300497 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under P200045. One submission often covers many models, so check the product and lot details in each record.
- Z-1383-2024 · Feb 22, 2024 · CompletedRELAY PRO Thoracic Stent-Graft System, containing one endovascular stent-graft system, IFU, and patient tracking card, sterile: (a) Part number 28-M4-34-100-34U; (b) Part number 2
Other System, Endovascular Graft, Aortic Aneurysm Treatment devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026 · each recall links to the FDA recall notice
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page